Vernakalant versus Amiodarone for post-operative atrial fibrillation in Cardiac Surgery Patients
Atrial FibrillationThis study is comparing two different anti-arrhythmic agents in patients that develop atrial fibrillation soon after cardiac surgery.
null
Participation Requirements
-
Sex:
Male, Female, Intersex -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
Patients 18 years or older who have coronary bypass surgery or valve repair/replacement.
Exclusion Criteria:
1) Patients who are too sick and unstable after surgery
2) Mechanical valves or ventricular assist device
3) Atrial fibrillation ablation (MAZE) during cardiac surgery
4) History of atrial fibrillation in the past
5) Abnormal ECG parameters
6) Allergies to vernkalant or amiodarone
7) Major liver or lung disease
Study Location
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contact Study Team
- Study Sponsored By
- University of Calgary
- Participants Required
- More Information
- Study ID:
REB20-2257